What treatment changes are recommended for an 18-year-old female with depression, anxiety, self-harm thoughts, and severe acid reflux, currently taking multiple medications?

Treatment Recommendations for This Patient

This patient requires immediate intensification of psychiatric care with addition of cognitive behavioral therapy (CBT) and close safety monitoring, while continuing current medications given her reported subjective improvement despite concerning discrepancies in her clinical presentation.

Critical Safety Concerns

The most alarming aspect of this case is the significant discordance between the patient's self-report and documented clinical reality:

• The therapy note documents active and passive suicidal ideation with fluctuating intent reaching 8/10, plus self-harm thoughts 1
• Yet the psychiatric assessment states she "denies suicidal ideation and feels like her meds are at a good place" 1
• This minimization of symptoms to the prescriber while disclosing severe ideation to the therapist represents a high-risk pattern requiring immediate intervention 2

Immediate actions required:

• Implement weekly or biweekly follow-up rather than the planned 6-8 weeks 1
• Coordinate care between therapist and prescriber to ensure consistent safety monitoring 3
• Use structured assessment tools (PHQ-9 including the self-harm item) at each visit to track suicidal ideation objectively 1
• Ensure no access to lethal means beyond the documented absence of firearms 1

Psychotherapy Addition

Add evidence-based psychotherapy immediately - specifically CBT, which should be the cornerstone of treatment for this young adult with depression, anxiety, and suicidal ideation 4:

• CBT has equivalent efficacy to antidepressants for depression with moderate-quality evidence, but importantly has lower relapse rates than medication alone 4
• For comorbid depression and anxiety (which this patient clearly has), CBT addresses both conditions effectively 5, 6
• The American College of Physicians recommends clinicians select between CBT or second-generation antidepressants as first-line treatment, with strong consideration for CBT where available 4
• Combined treatment (medication plus psychotherapy) shows superior outcomes compared to either alone, with standardized mean differences of 0.30 over psychotherapy alone and 0.33 over medication alone 3

Given her history of multiple medication trials with variable success, adding structured psychotherapy is essential rather than further medication adjustments at this time 4.

Medication Management

Continue current regimen (venlafaxine 187.5 mg, gabapentin 300 mg, hydroxyzine 25 mg PRN) for now, based on the following rationale:

• Venlafaxine is specifically effective for comorbid depression and anxiety, with demonstrated efficacy for both conditions 7, 8, 6
• The patient reported subjective improvement to the psychiatrist, suggesting some medication benefit 1
• Her current dose of venlafaxine (187.5 mg) is in the therapeutic range but could be optimized upward if needed after safety is stabilized 7

Do not make medication changes immediately because:

• The priority is establishing safety and adding psychotherapy, not medication adjustments 3
• Multiple prior medication failures suggest this patient may benefit more from psychotherapy augmentation than another medication switch 4
• Medication changes during acute suicidal ideation require extremely close monitoring 2

Monitoring and Follow-up Structure

Implement collaborative care approach with systematic follow-up 3:

• Schedule appointments every 1-2 weeks initially (not 6-8 weeks as currently planned) 1, 3
• Use PHQ-9 at every visit to objectively track depression severity and suicidal ideation 1
• Ensure communication between therapist and psychiatrist occurs regularly, not just through chart review 3
• Document safety planning explicitly at each visit 1

Special Considerations

Address the acid reflux-anxiety interaction: The patient has severe acid reflux which can exacerbate anxiety 1. Ensure gastroesophageal reflux disease is adequately managed by her primary care provider, as physical symptoms can perpetuate anxiety 1.

Nicotine cessation support: She reports wanting to quit vaping 1. Once acute psychiatric symptoms stabilize, offer evidence-based smoking cessation support, as nicotine can worsen anxiety 1.

Developmental context: At 18 years old with plans for college and employment, this patient is at a critical developmental transition 1. Psychotherapy should address these stressors and build coping skills for this life stage 9.

What NOT to Do

• Do not extend follow-up to 6-8 weeks as currently planned - this is unsafe given documented suicidal ideation 1, 2
• Do not switch antidepressants immediately - the current medication appears partially effective and changes require close monitoring 3
• Do not rely solely on patient self-report - use structured assessments given the documented minimization pattern 1
• Do not treat in isolation - coordinate with the therapist who is receiving more accurate clinical information 3